The Government has today announced an $69 million boost in funding for research in to rare cancers and rare diseases, including $26 million allocated to 19 projects as a part of the Medical Research Future Fund’s “Rare Cancers, Rare Diseases and Unmet Needs Clinical Trials Program”. This program has been expanded from $13 million when announced last year to $26 million in recognition of the quality of the applications received.
A $10 million targeted call for research into rare diseases and cancers is expected soon, and an additional $33 million will be made available in the next financial year to further expand research in this area.
Research Australia welcomes the additional funding, and recognises the importance of funding for these areas which impact many Australian families.
Last year Research Australia made a submission to the Senate Select Committee Inquiry into Funding for Research into Cancers with Low Survival Rates, which you can read in full here.
You can keep a track of all of the Medical Research Future Fund funding announcements here, or click here to read the Minister for Health’s full statement on today’s funding boost.
In its pre-Budget submission to the Treasurer, Research Australia has urged the Government to remain committed to the full implementation of the National Innovation and Science Agenda, continue funding of the MRFF’s capital in accordance with the existing timetable, and emphasised the need to at least maintain real levels of funding for the NHMRC and ARC grant programs.
The submission also raises the looming issue of the funding of indirect research costs associated with MRFF grants. Research Australia has called for MRFF grants to be included as Category 1 income for universities’ Research Block Grants and for their inclusion in the IRIISS scheme for MRIs in the short term, and echoes the MRFF Advisory Board’s call for a whole of government approach to this issue in the longer term.
Pre Budget Submission